CD169 identifies an activated CD8⁺ T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients

Reference

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65:87-108; PMID:25651787; http://dx.doi.org/10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Ceelen W, Van Nieuwenhove Y, Pattyn P. Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol 2010; 17:2847-55; PMID:20559741; http://dx.doi.org/10.1245/s10434-010-1158-1
   PubMed Web of Science ®Google Scholar
• Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer 2010; 116:2560-70; PMID:20499400; http://dx.doi.org/10.1002/cncr.25032
   PubMed Web of Science ®Google Scholar
• Lee KY. Lymph node ratio for nodal staging in colorectal cancer - a promising, but premature tool. J Korean Soc Coloproctol 2011; 27:224-5; PMID:22102970; http://dx.doi.org/10.3393/jksc.2011.27.5.224
   PubMedGoogle Scholar
• Qiu HB, Chen G, Keshari RP, Luo HY, Fang W, Qiu MZ, Zhou ZW, Xu RH. The extramural metastasis might be categorized in lymph node staging for colorectal cancer. BMC Cancer 2011; 11:414; PMID:21943144; http://dx.doi.org/10.1186/1471-2407-11-414
   PubMed Web of Science ®Google Scholar
• Resch A, Langner C. Lymph node staging in colorectal cancer: old controversies and recent advances. World J Gastroenterol 2013; 19:8515-26; PMID:24379568; http://dx.doi.org/10.3748/wjg.v19.i46.8515
   PubMed Web of Science ®Google Scholar
• Buettner M, Bode U. Lymph node dissection–understanding the immunological function of lymph nodes. Clin Exp Immunol 2012; 169:205-12; PMID:22861359; http://dx.doi.org/10.1111/j.1365-2249.2012.04602.x
   PubMed Web of Science ®Google Scholar
• Contassot E, Preynat-Seauve O, French L, Huard B. Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction. Trends Immunol 2009; 30:569-73; PMID:19837632; http://dx.doi.org/10.1016/j.it.2009.08.001
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID, Quirke P, Schmoll HJ. Has the new TNM classification for colorectal cancer improved care? Nat Rev Clin Oncol 2012; 9:119-23; PMID:22009076; http://dx.doi.org/10.1038/nrclinonc.2011.157
   PubMed Web of Science ®Google Scholar
• van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol 2010;10:664-74; PMID:20706277; http://dx.doi.org/10.1038/nri2832
   PubMed Web of Science ®Google Scholar
• Houston SA, Cerovic V, Thomson C, Brewer J, Mowat AM, Milling S. The lymph nodes draining the small intestine and colon are anatomically separate and immunologically distinct. Mucosal Immunol 2015; 9:468-78; PMID:26329428; http:/dx.doi.org/10.1038/mi.2015.77
   PubMed Web of Science ®Google Scholar
• Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, Tsarfaty I, Hudson E, Jackson DG, Petillo D et al. The. Preparing the “soil”: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res 2006; 66:10365-76; PMID:17062557; http://dx.doi.org/10.1158/0008-5472.CAN-06-2977
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.1203486
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang C, Li W, Deng J, Herrmann A, Priceman SJ, Liang W, Shen S, Pal SK, Hoon DS et al. CD8+ T-cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulation. Eur J Immunol 2015; 45:71-81; PMID:25310972; http://dx.doi.org/10.1002/eji.201444467
   PubMed Web of Science ®Google Scholar
• Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654-66; PMID:16371631; http://dx.doi.org/10.1056/NEJMoa051424
   PubMed Web of Science ®Google Scholar
• Galon J, Angell HK, Bedognetti D, Marincola FM. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 2013; 39:11-26; PMID:23890060; http://dx.doi.org/10.1016/j.immuni.2013.07.008
   PubMed Web of Science ®Google Scholar
• Pages F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 2009; 27:5944-51; PMID:19858404; http://dx.doi.org/10.1200/JCO.2008.19.6147
   PubMed Web of Science ®Google Scholar
• Nakamura K, Ninomiya I, Oyama K, Inokuchi M, Kinami S, Fushida S, Fujimura T, Kayahara M, Ohta T. Evaluation of immune response according to the metastatic status in the regional lymph nodes in patients with gastric carcinoma. Oncol Rep 2010; 24:1433-41; PMID:21042737; http://dx.doi.org/10.3892/or_00001003
   PubMed Web of Science ®Google Scholar
• Wu X, Zhang H, Xing Q, Cui J, Li J, Li Y, Tan Y, Wang S. PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients. Br J Cancer 2014; 111:1391-9; PMID:25093496; http://dx.doi.org/10.1038/bjc.2014.416
   PubMed Web of Science ®Google Scholar
• Klaas M, Crocker PR. Sialoadhesin in recognition of self and non-self. Semin Immunopathol 2012; 34:353-64; PMID:22450957; http://dx.doi.org/10.1007/s00281-012-0310-3
   PubMed Web of Science ®Google Scholar
• Martinez-Pomares L, Gordon S. CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol 2012; 33:66-70; PMID:22192781; http://dx.doi.org/10.1016/j.it.2011.11.001
   PubMed Web of Science ®Google Scholar
• Saunderson SC, Dunn AC, Crocker PR, McLellan AD. CD169 mediates the capture of exosomes in spleen and lymph node. Blood 2014; 123:208-16; PMID:24255917; http://dx.doi.org/10.1182/blood-2013-03-489732
   PubMed Web of Science ®Google Scholar
• Asano K, Nabeyama A, Miyake Y, Qiu CH, Kurita A, Tomura M, Kanagawa O, Fujii S, Tanaka M. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 2011; 34:85-95; PMID:21194983; http://dx.doi.org/10.1016/j.immuni.2010.12.011
   PubMed Web of Science ®Google Scholar
• Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra GS, Cerundolo V, Batista FD. CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol 2010; 11:303-12; PMID:20228797; http://dx.doi.org/10.1038/ni.1853
   PubMed Web of Science ®Google Scholar
• Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012; 150:1235-48; PMID:22980983; http://dx.doi.org/10.1016/j.cell.2012.07.021
   PubMedGoogle Scholar
• Bernhard CA, Ried C, Kochanek S, Brocker T. CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells. Proc Natl Acad Sci USA 2015; 112:5461-6; PMID:25922518; http://dx.doi.org/10.1073/pnas.1423356112
   PubMed Web of Science ®Google Scholar
• Ohnishi K, Komohara Y, Saito Y, Miyamoto Y, Watanabe M, Baba H, Takeya M. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Sci 2013; 104:1237-44; PMID:23734742; http://dx.doi.org/10.1111/cas.12212
   PubMed Web of Science ®Google Scholar
• General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese research society for cancer of the colon and rectum. Jpn J Surg 1983; 13:557-73; PMID:6672390; http://dx.doi.org/10.1007/BF02469505
   PubMedGoogle Scholar
• Grinnell RS. Lymphatic metastases of carcinoma of the colon and rectum. Ann Surg 1950; 131:494-506; PMID:17859481; http://dx.doi.org/10.1097/00000658-195004000-00004
   PubMed Web of Science ®Google Scholar
• Kuang DM, Zhao Q, Xu J, Yun JP, Wu C, Zheng L. Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathways. J Immunol 2008; 181:3089-98; PMID:18713979; http://dx.doi.org/10.4049/jimmunol.181.5.3089
   PubMed Web of Science ®Google Scholar
• Kuang DM, Zhao Q, Peng C, Xu J, Zhang JP, Wu C, Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 2009; 206:1327-37; PMID:19451266; http://dx.doi.org/10.1084/jem.20082173
   PubMed Web of Science ®Google Scholar
• Zhao Q, Kuang DM, Wu Y, Xiao X, Li XF, Li TJ, Zheng L. Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. J Immunol 2012; 188:1117-24; PMID:22184722; http://dx.doi.org/10.4049/jimmunol.1100164
   PubMed Web of Science ®Google Scholar
• Sathaliyawala T, Kubota M, Yudanin N, Turner D, Camp P, Thome JJ, Bickham KL, Lerner H, Goldstein M, Sykes M et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 2013; 38:187-97; PMID:23260195; http://dx.doi.org/10.1016/j.immuni.2012.09.020
   PubMed Web of Science ®Google Scholar
• Li L, Yan J, Xu J, Liu CQ, Zhen ZJ, Chen HW, Ji Y, Wu ZP, Hu JY, Zheng L et al. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma. PLoS One 2014; 9: e110064; PMID:25303284; http://dx.doi.org/10.1371/journal.pone.0110064
   PubMedGoogle Scholar
• Saito Y, Ohnishi K, Miyashita A, Nakahara S, Fujiwara Y, Horlad H, Motoshima T, Fukushima S, Jinnin M, Ihn H et al. Prognostic significance of CD169+ lymph node sinus macrophages in patients with malignant melanoma. Cancer Immunol Res 2015; 3:1356-63; PMID:26297710; http://dx.doi.org/10.1158/2326-6066.CIR-14-0180
   PubMed Web of Science ®Google Scholar
• Fujii TY, Tabe R, Yajima S, Yamaguchi S, Tsutsumi T, Asao & H. Kuwano. Process of distant lymph node metastasis in colorectal carcinoma: implication of extracapsular invasion of lymph node metastasis. BMC Cancer 2011; 11: 216; PMID:21635742; http://dx.doi.org/10.1186/1471-2407-11-216
   PubMedGoogle Scholar
• Kawada K, Taketo MM. Significance and mechanism of lymph node metastasis in cancer progression. Cancer Res 2011; 71:1214-8; PMID:21212413; http://dx.doi.org/10.1158/0008-5472.CAN-10-3277
   PubMed Web of Science ®Google Scholar
• Pereira ER, Jones D, Jung K, Padera TP. The lymph node microenvironment and its role in the progression of metastatic cancer. Semin Cell Dev Biol 2015; 38:98-105; PMID:25620792; http://dx.doi.org/10.1016/j.semcdb.2015.01.008
   PubMed Web of Science ®Google Scholar
• Swartz MA, Lund AW. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 2012; 12:210-9; PMID:22362216; http://dx.doi.org/10.1038/nrc3186
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013; 14:1014-22; PMID:24048123; http://dx.doi.org/10.1038/ni.2703
   PubMed Web of Science ®Google Scholar
• Chandrasekaran S, King MR. Microenvironment of tumor-draining lymph nodes: opportunities for liposome-based targeted therapy. Int J Mol Sci 2014; 15:20209-39; PMID:25380524; http://dx.doi.org/10.3390/ijms151120209
   PubMed Web of Science ®Google Scholar
• Fransen MF, Arens R, Melief CJ. Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment. Int J Cancer 2013; 132:1971-6; PMID:22858832; http://dx.doi.org/10.1002/ijc.27755
   PubMed Web of Science ®Google Scholar
• Sewald X, Ladinsky MS, Uchil PD, Beloor J, Pi R, Herrmann C, Motamedi N, Murooka TT, Brehm MA, Greiner DL et al. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science 2015; 350:563-7; PMID:26429886; http://dx.doi.org/10.1126/science.aab2749
   PubMed Web of Science ®Google Scholar
• Wong KP, Poon JT, Fan JK, Law WL. Prognostic value of lymph node ratio in stage III colorectal cancer. Colorectal Dis 2011; 13:1116-22; PMID:20874800; http://dx.doi.org/10.1111/j.1463-1318.2010.02435.x
   PubMed Web of Science ®Google Scholar
• Gray EE, Friend S, Suzuki K, Phan TG, Cyster JG. Subcapsular sinus macrophage fragmentation and CD169+ bleb acquisition by closely associated IL-17-committed innate-like lymphocytes. PLoS One 2012; 7: e38258; PMID:22675532; http://dx.doi.org/10.1371/journal.pone.0038258
   PubMedGoogle Scholar
• Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010; 28:264-71; PMID:19949014; http://dx.doi.org/10.1200/JCO.2009.24.0952
   PubMed Web of Science ®Google Scholar
• Compton C. C. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 2003; 16:376-88; PMID:12692203; http://dx.doi.org/10.1097/01.MP.0000062859.46942.93
   PubMed Web of Science ®Google Scholar